Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C

Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C - Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037575

Enrollment

1500

Registered

2019-08-01

Start date

2017-12-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are 20 years of age or older 2. Patients with chronic hepatitis C 3. Patients who are treated with interferon-free treatment

Exclusion criteria

Exclusion criteria: 1. Patients treated with contraindicated drug together with direct acting antivirals 2. Patients who were judged inadequate to participate by researchers.

Design outcomes

Primary

Measure	Time frame
sustained virological response rates at 24weeks after the end of treatment	—

Secondary

Measure	Time frame
factors contributing to sustained virological response appearance of RAS(resistant associated substitutions) occurrence of hepatocellular carcinoma factors associated with occurrence of hepatocellular carcinoma changes in liver fibrosis and liver function life prognosis	—

Countries

Japan

Contacts

Public ContactYuki Tahata

Graduate school of medicine, Osaka university department of gastroenterology and hepatology

yuki.tahata@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results